Overview

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576

Status:
Completed
Trial end date:
2020-09-03
Target enrollment:
Participant gender:
Summary
rVA576 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Phase:
Phase 3
Details
Lead Sponsor:
AKARI Therapeutics